Total Payments
$8,379
2024 Payments
$880.68
Companies
34
Transactions
307
Medicare Patients
8,775
Medicare Billing
$899,532
Payment Breakdown by Category
Food & Beverage$4,817 (57.5%)
Travel$3,418 (40.8%)
Education$144.25 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,817 | 293 | 57.5% |
| Travel and Lodging | $3,418 | 10 | 40.8% |
| Education | $144.25 | 4 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $1,529 | 8 | $0 (2019) |
| Inspire Medical Systems, Inc. | $1,286 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,245 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $832.36 | 64 | $0 (2024) |
| Veran Medical Technologies, Inc. | $672.56 | 3 | $0 (2018) |
| Mylan Specialty L.P. | $431.89 | 29 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $430.54 | 25 | $0 (2024) |
| Medical Device Business Services, Inc. | $228.15 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $188.74 | 25 | $0 (2019) |
| Baxter Healthcare | $161.28 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $880.68 | 24 | Medical Device Business Services, Inc. ($228.15) |
| 2023 | $1,709 | 29 | Inspire Medical Systems, Inc. ($1,286) |
| 2022 | $470.60 | 28 | AstraZeneca Pharmaceuticals LP ($196.70) |
| 2021 | $661.50 | 43 | AstraZeneca Pharmaceuticals LP ($207.93) |
| 2020 | $292.00 | 19 | AstraZeneca Pharmaceuticals LP ($156.81) |
| 2019 | $2,243 | 57 | Covidien LP ($1,506) |
| 2018 | $1,353 | 50 | Veran Medical Technologies, Inc. ($661.97) |
| 2017 | $768.44 | 57 | GlaxoSmithKline, LLC. ($184.84) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $88.99 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $228.15 | General |
| 11/05/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $140.32 | General |
| Category: Endo-Mechanical | ||||||
| 10/29/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Airway Clearance Device | ||||||
| 06/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Immunology | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Narcoplepsy | ||||||
| 05/22/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.84 | General |
| Category: HFCWO | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $35.99 | General |
| Category: Narcoplepsy | ||||||
| 04/03/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: HFCWO | ||||||
| 03/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Airway Clearance Device | ||||||
| 01/30/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiology | ||||||
| 01/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $27.33 | General |
| Category: SLEEP MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,742 | 2,373 | $481,470 | $167,718 |
| 2022 | 19 | 2,109 | 2,987 | $471,654 | $201,426 |
| 2021 | 21 | 2,446 | 3,524 | $521,693 | $260,452 |
| 2020 | 23 | 2,478 | 3,731 | $553,439 | $269,935 |
Total Patients
8,775
Total Services
12,615
Medicare Billing
$899,532
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 428 | 674 | $101,178 | $63,186 | 62.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 185 | 185 | $42,180 | $21,993 | 52.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 77 | 127 | $114,681 | $21,016 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 191 | $19,100 | $12,074 | 63.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 89 | $39,242 | $12,036 | 30.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 114 | $48,280 | $10,632 | 22.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 136 | $31,188 | $8,335 | 26.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 143 | 143 | $28,600 | $5,958 | 20.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 157 | 160 | $14,240 | $4,514 | 31.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 62 | 62 | $12,400 | $2,042 | 16.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $3,542 | $1,768 | 49.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 23 | 23 | $8,050 | $1,578 | 19.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 12 | 12 | $5,460 | $1,152 | 21.1% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 51 | 51 | $1,071 | $632.39 | 59.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 15 | 15 | $5,250 | $515.70 | 9.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 22 | 22 | $1,958 | $171.41 | 8.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 17 | 17 | $3,400 | $106.05 | 3.1% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 107 | 330 | $1,650 | $8.75 | 0.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 250 | 388 | $58,200 | $38,174 | 65.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 202 | 219 | $64,848 | $33,109 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 372 | 484 | $48,400 | $32,107 | 66.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 152 | 372 | $81,520 | $29,309 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 125 | 125 | $28,500 | $15,323 | 53.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 51 | 82 | $43,851 | $13,389 | 30.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 105 | 185 | $18,510 | $10,273 | 55.5% |
About Dr. Mohan Philip, M.D
Dr. Mohan Philip, M.D is a Critical Care Medicine healthcare provider based in Greenville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124093471.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohan Philip, M.D has received a total of $8,379 in payments from pharmaceutical and medical device companies, with $880.68 received in 2024. These payments were reported across 307 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,817).
As a Medicare-enrolled provider, Philip has provided services to 8,775 Medicare beneficiaries, totaling 12,615 services with total Medicare billing of $899,532. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Greenville, TX
- Active Since 02/21/2006
- Last Updated 02/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1124093471
Products in Payments
- superDimension (Device) $1,506
- INSPIRE (Device) $1,286
- Spin (Device) $672.56
- SYMBICORT (Drug) $510.76
- OFEV (Drug) $335.00
- TRELEGY ELLIPTA (Drug) $263.39
- Yupelri (Drug) $227.25
- BREZTRI (Drug) $218.73
- NUCALA (Biological) $210.87
- FASENRA (Biological) $178.00
- DUPIXENT (Biological) $177.21
- WAKIX (Drug) $159.08
- BEVESPI AEROSPHERE (Drug) $151.05
- ANORO (Drug) $148.09
- Monarch Platform (Device) $140.32
- Esbriet (Biological) $131.31
- OPSUMIT (Drug) $124.48
- Perforomist (Drug) $122.55
- Hillrom - Vest System Model 105 Home Care (Device) $117.30
- Prolastin-C Liquid (Biological) $84.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greenville
Nasir Awan, M.d, M.D
Critical Care Medicine — Payments: $34,640
Critical Care Medicine $34,640
Mohammad Ansari, M.d, M.D
Critical Care Medicine — Payments: $10,749
Critical Care Medicine $10,749
Charles Mullen, Md, MD
Critical Care Medicine — Payments: $7,075
Critical Care Medicine $7,075
Ahmad Boota, Md, MD
Critical Care Medicine — Payments: $4,026
Critical Care Medicine $4,026
Kimberly Smith, Rn, RN
Critical Care Medicine — Payments: $3,640
Critical Care Medicine $3,640
Dr. Christy Sine, Md, MD
Critical Care Medicine — Payments: $3,525
Critical Care Medicine $3,525